PCVX R&D Expenses
Vaxcyte Inc · R&D Expenses
PCVX R&D Expenses
Latest reported$1.03Bperiod ending
PCVX TTM R&D Expenses ($45.61M → $1.03B)
TTM R&D Expenses
High-resolution chart · PNG
PCVX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 1,032,624,000 | |
| 958,951,000 | |
| 794,306,000 | |
| 685,860,000 | |
| 592,863,000 | |
| 530,191,000 | |
| 476,644,000 | |
| 447,180,000 | |
| 427,665,000 | |
| 368,849,000 | |
| 332,342,000 | |
| 279,818,000 | |
| 230,076,000 | |
| 195,854,000 | |
| 169,452,000 | |
| 140,900,000 | |
| 113,649,000 | |
| 92,831,000 | |
| 78,411,000 | |
| 69,998,000 | |
| 65,980,000 | |
| 66,507,000 | |
| 73,564,000 | |
| 72,285,000 | |
| 65,505,000 | |
| 57,295,000 | |
| 45,608,000 |